Standard
The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells. / Munir, Shamaila; Andersen, Gitte Holmen; Svane, Inge Marie; Andersen, Mads Hald.
I:
OncoImmunology, Bind 2, Nr. 4, e23991, 2013.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Munir, S, Andersen, GH
, Svane, IM & Andersen, MH 2013, '
The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells',
OncoImmunology, bind 2, nr. 4, e23991.
https://doi.org/10.4161/onci.23991
APA
Munir, S., Andersen, G. H.
, Svane, I. M., & Andersen, M. H. (2013).
The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells.
OncoImmunology,
2(4), [e23991].
https://doi.org/10.4161/onci.23991
Vancouver
Munir S, Andersen GH
, Svane IM, Andersen MH.
The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells.
OncoImmunology. 2013;2(4). e23991.
https://doi.org/10.4161/onci.23991
Author
Munir, Shamaila ; Andersen, Gitte Holmen ; Svane, Inge Marie ; Andersen, Mads Hald. / The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells. I: OncoImmunology. 2013 ; Bind 2, Nr. 4.
Bibtex
@article{606b7c418447411eb1902a367a3941ff,
title = "The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells",
author = "Shamaila Munir and Andersen, {Gitte Holmen} and Svane, {Inge Marie} and Andersen, {Mads Hald}",
year = "2013",
doi = "10.4161/onci.23991",
language = "English",
volume = "2",
journal = "OncoImmunology",
issn = "2162-4011",
publisher = "Taylor & Francis",
number = "4",
}
RIS
TY - JOUR
T1 - The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4(+) T cells
AU - Munir, Shamaila
AU - Andersen, Gitte Holmen
AU - Svane, Inge Marie
AU - Andersen, Mads Hald
PY - 2013
Y1 - 2013
U2 - 10.4161/onci.23991
DO - 10.4161/onci.23991
M3 - Journal article
C2 - 23734334
VL - 2
JO - OncoImmunology
JF - OncoImmunology
SN - 2162-4011
IS - 4
M1 - e23991
ER -